SCHEMBL8930238

SCHEMBL8930238

CC(C)OC(=O)c1cc(NC(=O)C(C)(C)C)c(F)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 2/20 0.40
APEX1 P27695 1/20 0.40
KDM4E B2RXH2 2/20 0.39
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
AURKA O14965 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CDK3 Q00526 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10647200 0.84 MAPT (0.46) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL11020212 0.81 LMNA (0.48) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL10421286 0.79 LMNA (0.42) LMNAMAPTHPGDSMN1; SMN2GAA
SCHEMBL8930017 0.79 NPC1 (0.53) LMNAMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13981047 0.79 LMNA (0.47) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL9247954 0.79 HPGD (0.56) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL13799202 0.77 LMNA (0.43) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL9204064 0.76 SMN1; SMN2 (0.39) LMNAMAPTHPGDSMN1; SMN2POLB
SCHEMBL11206454 0.76 NPSR1 (0.42) LMNAMAPTHPGDSMN1; SMN2RAB9A
SCHEMBL13479860 0.75 MAPT (0.46) LMNAMAPTHPGDSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693827-A Treatment of HIV infections and compounds useful therein UNIROYAL CHEMICAL COMPANY, INC. 1997-12-02 US disclosed
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed